Monoclonal antibodies(mAbs) are just like antibodies except they are artificially produced from the clones of a single cell. The mAbs market is expected to almost triple in value over the next six years from $10.3 billion in 2004 to $30.3 billion.
More information on Monoclonal Antibodies
No comments:
Post a Comment